as everyone should f'n know, not good that MELA doing a stock offering before FDA news. this appears to indicate the FDA will reject or require much more studies.
100% agree. Mgmt team knows something and is not telling investors. This stock offering makes sense in that context.I am guessing FDA probably has requested more information and it's possible it's an outright rejection due to the information FDA has requested.
<< this appears to indicate the FDA will reject or require much more studies >>Are you stooopid or just ignaaaant?